SLYND (drospirenone)


SELF ADMINISTRATION - Oral


Indications for Prior Authorization: 
  • Slynd® is a progestin indicated for use by females of reproductive potential to prevent pregnancy. 
Prior Authorization Criteria:
  • Patient has tried and failed a preferred Norethindrone (progesterone only) contraceptive (e.g., Camila®, Errin®, Heather, Incassia®, Jencycla™) as confirmed by prior authorization documentation and/or paid prescription claims history. 
Dosing:
  • One tablet is taken daily for 28 days (one white active tablet daily during the first 24 days and one green inert tablet daily during the 4 following days). 
Approval:
  • 1 year
     

 

 

 

 

 

 

 

 

 

 

 

 

 

Last review date: July 30, 2020